Study Title

Phase II Trial of 18F-DCFPyL Imaging as a Method to Assess Treatment Response to Stereotactic Body Radiation Therapy

Study Details

Description:

Identifying medium- and high-risk prostate cancer early may allow for treatments to work. But identification can be hard. Researchers want to see if a radiotracer used during PET scans can help.

Sponsor:

National Cancer Institute

© 2021 XCancer Software LLC

Contact XCancer: 402-991-8468